Articles

Why I Developed Lectures On Innovation

Why I Developed Lectures On Innovation

During the course of my career, I have seen fortunes made and fortunes lost. I have seen companies start in a basement and within five years sell for tens or hundreds of millions of dollars. I have also seen entrepreneurs having to sell their homes and cars and move...

read more
Update on Nitrosamine Impurities in Pharmaceutical Products

Update on Nitrosamine Impurities in Pharmaceutical Products

Health Canada has updated its assessment requirements for Nitrosamines in pharmaceutical products. Nitrosamines are, defined by the World Health Organization, as “any molecule containing the nitroso functional group. These molecules are of concern because nitrosamine...

read more
New Changes to Health Canada’s Cosmetic Ingredient Hotlist

New Changes to Health Canada’s Cosmetic Ingredient Hotlist

Earlier this month, Health Canada released a list of new amendments to both the Restricted and Prohibited Cosmetic Ingredient Hotlists. The list included changes to the classification or conditions of use on four ingredients, all already present on the Cosmetic...

read more
Feeling Blue: Can Blue Light Damage Your Skin?

Feeling Blue: Can Blue Light Damage Your Skin?

While the general public is largely aware of the harmful effects ultraviolet (UV) light can have on our bodies, as well as the basic measures that should be taken to protect ourselves against such effects, the dangers surrounding blue light seem to go relatively left...

read more
EPA’s Proposed Prioritization of Chemical Substances

EPA’s Proposed Prioritization of Chemical Substances

Last month the United States Environmental Protection Agency (EPA) released a list of 20 chemical substances that they proposed be designated as High Priority Substances. The list, which was released as required under the Toxic Substances Control Act (TSCA), is...

read more
503A Bulks List Prepares for Five Potential New Additions

503A Bulks List Prepares for Five Potential New Additions

The U.S. Food and Drug Administration (FDA) has officially released a proposed rule to amend the list of bulk drug substances that can be used to compound drug products with the addition of five new substances to the list. If approved, glutaraldehyde, glycolic acid,...

read more
Update on Titanium Dioxide in Sunscreens

Update on Titanium Dioxide in Sunscreens

Currently, the Canadian Natural Health Products Ingredients Database (NHPID) lists Titanium dioxide (TiO2) as an opacifying agent and color additive for topical use, but is NOT permitted in sunscreens for these uses. However, according to Cosmetics Alliance Canada,...

read more

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs.  Our team has the experience and expertise you need to see your product to market and we are eager to help you.